Dr. Sznol Discusses the Role of Surgery in Melanoma

Mario Sznol, MD
Published: Friday, Dec 08, 2017



Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the role of surgery in the treatment of patients with melanoma.

The role of surgery in melanoma is not going away, says Sznol. Even with the effective systemic therapies in place for this disease, sometimes surgery is warranted and can lead to a longer survival.

Although several patients in the metastatic setting tend to benefit from immunotherapy, some patients will not achieve a complete response and lesions will remain. If those lesions are resected, some patients remain progression-free for a long period of time.
 


Mario Sznol, MD, professor of medicine, co-director, Yale SPORE in Skin Cancer, Yale Cancer Center, discusses the role of surgery in the treatment of patients with melanoma.

The role of surgery in melanoma is not going away, says Sznol. Even with the effective systemic therapies in place for this disease, sometimes surgery is warranted and can lead to a longer survival.

Although several patients in the metastatic setting tend to benefit from immunotherapy, some patients will not achieve a complete response and lesions will remain. If those lesions are resected, some patients remain progression-free for a long period of time.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x